Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $2916.0.

  • Baird Medical Investment Holdings' Receivables - Other changed N/A to $2916.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $2916.0, marking a year-over-year change of. This contributed to the annual value of $394582.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Baird Medical Investment Holdings reported Receivables - Other of $2916.0 as of Q2 2025.
  • Over the past 5 years, Baird Medical Investment Holdings' Receivables - Other peaked at $394582.0 during Q4 2023, and registered a low of $2862.0 during Q4 2024.
  • Its 3-year average for Receivables - Other is $133453.3, with a median of $2916.0 in 2025.
  • Over the last 5 years, Baird Medical Investment Holdings' Receivables - Other had its largest YoY gain of 9927.47% in 2024, and its largest YoY loss of 9927.47% in 2024.
  • Quarter analysis of 3 years shows Baird Medical Investment Holdings' Receivables - Other stood at $394582.0 in 2023, then tumbled by 99.27% to $2862.0 in 2024, then rose by 1.89% to $2916.0 in 2025.
  • Its last three reported values are $2916.0 in Q2 2025, $2862.0 for Q4 2024, and $394582.0 during Q4 2023.